eHealth Tallinn

Sponsorship Opportunities

eHealth Tallinn is a unique conference where we will address how digital technologies and the wider use of health data are changing our lives and the ways of healthcare.

Join us but be quick - our packages are selling out fast! We can't wait to welcome you in Tallinn, the city where historic ambience and cutting-edge culture mix together. Get in touch with Adeline Goffin today and discuss the best sponsorship and exhibitor opportunities for your needs.

Our Sponsors and Exhibitors

Gold Sponsors

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients.

For nearly 350 years, curious people have been bringing ideas to life at Merck. Since then, we have become a truly global company, with 50,000 employees in 66 countries working on breakthrough solutions and technologies. As a global science and technology company, a passion for research and discovery is our most valuable resource. With our three business sectors, namely Healthcare, Life Science and Performance Materials, we improve the quality of life of patients, increase the success of our customers, and offer solutions for diverse challenges. Curiosity is and remains our strongest driving force for future-oriented innovations.

Merck Biopharma business discovers, develops, manufactures and markets innovative pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders as well as certain cardiovascular and metabolic diseases.

Our streamlined R&D pipeline positions us with a clear focus on becoming a leading science-driven innovator in oncology, immuno-oncology and immunology, including multiple sclerosis.

Health needs are infinite, but resources are finite. Microsoft platforms and services lay the trusted foundation for solutions that help health providers and payors, public health or social services agencies, and pharmaceutical companies improve patient and employee experiences, empower researchers, and enhance products and services in the face of increasing cost pressures. Microsoft supports the work of the Cloud in Health Advisory Council, aiming to foster cloud policies and solutions that empower a healthier, more sustainable future for all.

For more than a century, MSD (known as Merck & Co. Inc., in the US and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare.

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and CNS plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, fuel the growth of Takeda.

Estonian Connected Health Pavilion

Connected Health is a country-wide partnership between health related stakeholders in Estonia, who are committed to accelerating the adoption of connected health solutions, at scale internationally on commercial terms. Cluster brings together 70+ partners, including companies (start-ups, health IT, medtech, biotech and pharma), R&D partners (universities and technology competence centres), health and wellness service providers (hospitals, GPs, occupational health, spas, fitness and sports), patient organisations and user communities, and public sector (ministries responsible for healthcare and entrepreneurship, national health insurance, national e-health development agency). Cluster is part of the European Connected Health Alliance and ScanBalt network.

Cognuse enables the Continuum of Care for critical illness with a digital tool set for early screening of complications, interfaces for patient and family member empowerment in supporting early mobilization and monitoring the care environment with actionable feedback to the clinical and administrative staff. Correlative analysis is performed for all stages to support the evidence-based backbone of the platform. A dynamic transfer between care phases is complemented by post-discharge follow-up and support.

Dermtest is a platform for country-wide skin-cancer prevention, detection, treatment and follow-up. We connect patients, providers and payors for providing a comprehensive digitalized population health programme. The goal is to increase regional access, quality and cost-efficiency of skin disease detection and treatment. We have a EU data protection seal and a change management support service for fast and easy implementation. Dermtest is operational in Estonia, Germany and Lithuania and used by 150 clinicians.

Helmes was established in 1991 and we have currently 260+ employees in Tallinn and Minsk, Belarus. Our strongest competence is integration of business critical software and creation of modern solutions. Helmes medicine sector teams combine the expertise of engineering with the experience of innovating hospital workflows. The teams operate like a development unit within a hospital – their focus is always on improving workflows towards increase in the quality of care and better utilization of all resources.

Industry62 (i62) is on hand to help you to create digital solutions that make a difference. Thanks to our ample expertise in service design, business analysis, software architecture, and development, we know that trust and people are what truly matters. Our team has extensive experience in e-health, telecoms, banking, forest management, and sports betting. Our clients primarily operate in New York, London, Luxembourg, Tallinn, Helsinki, Stockholm, and San Francisco. Started in 2005, i62 is owned by its employees.

Nortal is a multinational strategic change and technology company. Combining the unique experience of transforming Estonia into a digital leader and creating change in businesses with a strategic approach and data-driven technology, our vision is to build a seamless society. Nortal operates in nearly 20 countries and employs over 600 specialists who carry out high-impact projects across Europe, Middle East, Africa and the United States.

Quretec provides full package of clinical data management services and software solutions for web based electronic data collection. Our main product Qure Data Management platform is well suitable for national medical registers (cancer, HIV, tuberculosis, birth and causes of death registries in Estonia), biobanks (Estonian Genome Center), clinical trials data management (EDC, eTraining), feasibility studies, and national statistics (Estonian Census). Quretec provides clinical trials data management, biostatistics and bioinformatics services.


Clinerion's medical data informatics radically improve efficiency in patient recruitment, increase effectiveness in clinical research and accelerate drug development to ensure a faster availability of medicines. With tools for testing protocol feasibility, site feasibility, and patient search, we support partner hospitals in accessing leading-edge sponsored trials; and enable life sciences company clients to gain massive time and cost savings. Clinerion big data analytics also support the generation of data for real-world evidence, and market access for precision medicines for rare and orphan diseases.

EU Project Pavilion Partners


i-PROGNOSIS is an EU-funded multiscope research project aiming to provide technology-based solutions against Parkinson’s. The main objectives of i-PROGNOSIS are: i) to develop early and unobtrusive Parkinson’s disease detection tests based on the interaction of users with their everyday technological devices, and ii) design interventions to help Parkinson’s patients sustain their quality of life. In this way, i-PROGNOSIS will raise awareness, support self-health management and empower people to affect policies and reduce hospitalization. .

KRISTINA is a EU funded research project, which aims at developing technologies for a human-like competent and communicative agent to support migrants in Spain and Germany within the National Health Systems. The system runs on communication devices and serves for migrants with language and cultural barriers in the host country. KRISTINA provides health information and it will advance the state of art in multimodal communication in Spanish, German, Turkish, Polish and Arabic.